Animal models in preclinical metastatic breast cancer immunotherapy research: A systematic review and meta-analysis of efficacy outcomes.
Breast cancer, particularly metastatic breast cancer (MBC), presents aggressive clinical challenges with limited treatment success. Immunotherapy has emerged as a promising approach, however, discrepancies between preclinical animal models and human cancers complicate translation to clinical outcome...
Saved in:
| Main Authors: | Yalda Mirzaei, Martina Hüffel, Sarah McCann, Alexandra Bannach-Brown, René H Tolba, Julia Steitz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0322876 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
External validity in translational biomedicine: understanding the conditions enabling the cause to have an effect
by: Ulrich Dirnagl, et al.
Published: (2021-12-01) -
INTRAPLEURAL IMMUNOTHERAPY FOR METASTATIC PLEURISIES IN PATIENTS WITH BREAST CANCER
by: K. S. Titov, et al.
Published: (2014-09-01) -
Immunological barriers to immunotherapy in primary and metastatic breast cancer
by: Mara De Martino, et al.
Published: (2021-06-01) -
The evolving landscape of genetic biomarkers for immunotherapy in primary and metastatic breast cancer
by: Liang Jin, et al.
Published: (2025-03-01) -
Immunotherapy in metastatic prostate cancer
by: Liam Dwyer, et al.
Published: (2025-06-01)